FdaApplication

BLA 125795

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTakeda Pharmaceuticals U.S.A., Inc.
application_typeBLA
approval_date2023-11-09

Products (2)

ProductActive ingredientStrengthDosage form
ADZYNMA—500IUFor Injection
ADZYNMA—1500IUFor Injection

2 products